1. Management of patients with advanced prostate cancer: the report of the advanced prostate cancer consensus conference APCCC 2017;Gillessen;Eur. Urol.,2019
2. An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis;Kicinski;PLoS One,2011
3. Inherited DNA-repair gene mutations in men with metastatic prostate cancer;Pritchard;N. Eng. J. Med.,2016
4. National Comprehensive Cancer Network, 2022b. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Prostate Adenocarcinoma. Version 1.2023-September 16, 2022. [Online]. https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.
5. National Comprehensive Cancer Network, 2022a. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 1.2023- September 7, 2022. [Online]. https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf.